ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Methylene Blue Does Not Improve Vasoplegia After Left Ventricular Assist Device Implantation

Friday, April 9, 2021

Submitted by

Catherine Joyce

Source

Source Name: The Annals of Thoracic Surgery

Source URL: https://doi.org/10.1016/j.athoracsur.2020.05.172

Author(s)

Amit Saha, MD, Douglas L. Jennings, PharmD, Yuming Ning, PhD, Paul Kurlansky, MD, Andrea N. Miltiades, MD, Jessica L. Spellman, MD, Joseph Sanchez, MD, Melana Yuzefpolskaya, MD, Paolo C. Colombo, MD, Hiroo Takayama, MD, PhD, Yoshifumi Naka, MD, PhD, and Koji Takeda, MD, PhD

This investigation studied the effectiveness of methylene blue (MB) for vasoplegia in LVAD recipients and found that clinical outcomes did not improve after LVAD implantation.